Entheon Biomedical: Looking to Remedy the Root Causes of Addiction

August 20, 2021

Focused on Addiction

With an expert team of scientists and world-class advisors, Entheon Biomedical is looking to remedy the root causes of addiction. Additionally, The company is well funded and is currently in phase one of its clinical trials program.

The focus of Entheon is on addiction. They plan to combat it by developing a unique treatment system using DMT. Furthermore, it's well tolerated with few adverse effects - pure DMT is the ideal molecule for advancing and sustaining new models of psychedelic-assisted therapy. Through an assisted therapeutic experience, Entheon will allow patients to erase problematic neural pathways fueling addiction and mental illness. Thus facilitating the creation of new pathways towards recovery.

The Advancement of DMT

DMT has been used therapeutically for hundreds of years in the form of ayahuasca. Moreover, it has been scientifically studied since at least the 1950s. Likewise, it has been present throughout the plant kingdom and is safe in humans.

For more information on Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF) please click the request investor info button.

You might also like

Psychedelics
Investor Alert: Entheon Biomedical - Treating Addiction

Entheon Biomedical is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective N …

Psychedelics
Small Pharma: Mental Health Solutions with Psychedelics

Small Pharma is a neuropharmaceutical company. They specialize in IP led development of novel treatments for mental health conditions, with a focus on …

Content Broadcast on: BNN Bloomberg, Bloomberg, FOX Business News, BIZTV, Reuters, YouTube and more!